AMERICAN VANGUARD CORP — Form 8-K
Filed August 11, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 45/100
What the filing says
American Vanguard (market cap $111.1M) reported H1 2026 net sales of $240M (down 2% YoY) with adjusted EBITDA of $16.9M (up 21% YoY). Q2 sales fell 10% to $117M; net loss widened to $9.9M vs. $849K loss YoY. Company reaffirmed full-year 2026 guidance: adjusted EBITDA $44–48M on sales $530–550M. Key actions: L.A. plant rationalization expected to save $4M annualized; inventory reduced $10M YoY; R&D spending up 12%; new SVP of Marketing hired. Management targets $600M revenue run rate by H2 2028 (20% above 2025) with double-digit EBITDA margins.
Why this rating
Mixed signals: margin expansion and cost discipline are positive; declining Q2 sales and widened losses offset H1 EBITDA growth. Guidance reaffirmation is stabilizing, but weak external markets limit upside. Event material to execution risk, not transformational.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.